Stem Cell Companies Beware: FDA May Come Knocking
January 28, 2019
Chad Landmon and Jonathan Knowles
Bloomberg BNA Insights
Axinn partner Chad Landmon and associate Jonathan Knowles* authored the Bloomberg BNA Insights article, "Stem Cell Companies Beware: FDA May Come Knocking."
Click here to access the article. Reproduced with permission from Copyright 2019 The Bureau of National Affairs, Inc. (800-372-1033) www.bna.com.
*At the time of this writing, Jonathan Knowles' admission to the New York bar is pending.